Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease
出版年份 2012 全文链接
标题
Bortezomib in the rapid reduction of high sustained antibody titers in disorders treated with therapeutic protein: lessons learned from Pompe disease
作者
关键词
-
出版物
GENETICS IN MEDICINE
Volume 15, Issue 2, Pages 123-131
出版商
Springer Nature
发表日期
2012-10-11
DOI
10.1038/gim.2012.110
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Assessing disease severity in Pompe disease: The roles of a urinary glucose tetrasaccharide biomarker and imaging techniques
- (2012) Sarah P. Young et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS
- Successful immune tolerance induction to enzyme replacement therapy in CRIM-negative infantile Pompe disease
- (2012) Yoav H. Messinger et al. GENETICS IN MEDICINE
- The emerging phenotype of long-term survivors with infantile Pompe disease
- (2012) Sean N. Prater et al. GENETICS IN MEDICINE
- The impact of antibodies in late-onset Pompe disease: A case series and literature review
- (2012) Trusha T. Patel et al. MOLECULAR GENETICS AND METABOLISM
- Persistence of high sustained antibodies to enzyme replacement therapy despite extensive immunomodulatory therapy in an infant with Pompe disease: Need for agents to target antibody-secreting plasma cells
- (2012) Suhrad G. Banugaria et al. MOLECULAR GENETICS AND METABOLISM
- The impact of antibodies on clinical outcomes in diseases treated with therapeutic protein: Lessons learned from infantile Pompe disease
- (2011) Suhrad G. Banugaria et al. GENETICS IN MEDICINE
- Enzyme replacement therapy induces T-cell responses in late-onset Pompe disease
- (2011) Miklos Banati et al. MUSCLE & NERVE
- Therapeutic Potential of Proteasome Inhibition in Duchenne and Becker Muscular Dystrophies
- (2010) Elisabetta Gazzerro et al. AMERICAN JOURNAL OF PATHOLOGY
- High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa
- (2010) Juna M. de Vries et al. MOLECULAR GENETICS AND METABOLISM
- Bortezomib: a new player in pre- and post-transplant desensitization?
- (2010) A. Lemy et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease
- (2009) Marc Nicolino et al. GENETICS IN MEDICINE
- Risk factors for inhibitor formation in haemophilia: a prevalent case-control study
- (2009) M. V. RAGNI et al. HAEMOPHILIA
- Rituximab and immune tolerance in severe hemophilia A: a consecutive national cohort
- (2009) P. W. COLLINS et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants
- (2009) Priya S. Kishnani et al. MOLECULAR GENETICS AND METABOLISM
- Elimination of Antibodies to Recombinant Enzyme in Pompe's Disease
- (2009) Nancy J. Mendelsohn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Early Treatment With Alglucosidase Alfa Prolongs Long-Term Survival of Infants With Pompe Disease
- (2009) Priya S Kishnani et al. PEDIATRIC RESEARCH
- Immune response to enzyme replacement therapy in Fabry disease: Impact on clinical outcome?
- (2008) C.E.M. Hollak et al. MOLECULAR GENETICS AND METABOLISM
- Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment
- (2008) Jinhai Wang et al. NATURE BIOTECHNOLOGY
- The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis
- (2008) Kirsten Neubert et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started